A biomimetic 3D model of hypoxia-driven cancer progression

被引:0
|
作者
Chiara Liverani
Alessandro De Vita
Silvia Minardi
Yibin Kang
Laura Mercatali
Dino Amadori
Alberto Bongiovanni
Federico La Manna
Toni Ibrahim
Ennio Tasciotti
机构
[1] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,Osteoncology and Rare Tumors Center
[2] Center for Biomimetic Medicine,Department of Molecular Biology
[3] Houston Methodist Research Institute (HMRI),Houston Methodist Orthopedics & Sports Medicine
[4] Princeton University,undefined
[5] Houston Methodist Hospital,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The fate of tumors depends both on the cancer cells’ intrinsic characteristics and on the environmental conditions where the tumors reside and grow. Engineered in vitro models have led to significant advances in cancer research, allowing the investigation of cells in physiological environments and the study of disease mechanisms and processes with enhanced relevance. Here we present a biomimetic cancer model based on a collagen matrix synthesized through a biologically inspired process. We compared in this environment the responses of two breast tumor lineages characterized by different molecular patterns and opposite clinical behaviors: MCF-7 that belong to the luminal A subtype connected to an indolent course, and basal-like MDA-MB-231 connected to high-grade and aggressive disease. Cancer cells in the biomimetic matrix recreate a hypoxic environment that affects their growth dynamics and phenotypic features. Hypoxia induces apoptosis and the selection of aggressive cells that acquire expression signatures associated with glycolysis, angiogenesis, cell-matrix interaction, epithelial to mesenchymal transition and metastatic ability. In response to hypoxia MDA-MB-231 migrate on the collagen fibrils and undergo cellular senescence, while MCF-7 do not exhibit these behaviors. Our biomimetic model mimics the evolution of tumors with different grade of aggressiveness fostered by a hypoxic niche and provides a relevant technology to dissect the events involved in cancer progression.
引用
收藏
相关论文
共 50 条
  • [41] Application of Hypoxia-Driven Dual-Reporter Model to Explore the Effect of Hypoxia on Radiosensitivity of Human Nasopharyngeal Carcinoma Cells
    Dong, J.
    Wen, B.
    Wang, C.
    Zhang, T.
    Wang, Z.
    Li, G.
    He, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E246 - E247
  • [42] RESVERATROL INHIBITS HYPOXIA-DRIVEN PANCREATIC STELLATE CELLS ACTIVATION AND PANCREATIC CANCER CELLS AGGRESSIVENESS
    Xu, Qinhong
    Sun, Liankang
    GASTROENTEROLOGY, 2018, 154 (06) : S284 - S284
  • [43] The effects of biofilms on tumor progression in a 3D cancer-biofilm microfluidic model
    Deng, Yanlin
    Liu, Sylvia Yang
    Chua, Song Lin
    Khoo, Bee Luan
    BIOSENSORS & BIOELECTRONICS, 2021, 180
  • [44] α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion
    Lei, Jianjun
    Huo, Xiongwei
    Duan, Wanxing
    Xu, Qinhong
    Li, Rong
    Ma, Jiguang
    Li, Xuqi
    Han, Liang
    Li, Wei
    Sun, Hao
    Wu, Erxi
    Ma, Qingyong
    CANCER LETTERS, 2014, 347 (01) : 129 - 138
  • [45] The genetics of cancer—a 3D model
    Kristina A. Cole
    David B. Krizman
    Michael R. Emmert–Buck
    Nature Genetics, 1999, 21 : 38 - 41
  • [46] The genetics of cancer - a 3D model
    Cole, KA
    Krizman, DB
    Emmert-Buck, MR
    NATURE GENETICS, 1999, 21 (Suppl 1) : 38 - 41
  • [47] Investigating the Impact of Hypoxia on Radiotherapy Response of a 3D Scaffold Based Pancreatic Cancer Model
    Wishart, Gabrielle
    Gupta, Priyanka
    Schettino, Giuseppe
    Nisbet, Andrew
    Velliou, Eirini G.
    TISSUE ENGINEERING PART A, 2023, 29 (13-14)
  • [48] Hypoxia-Driven M2-Polarized Macrophages Facilitate Cancer Aggressiveness and Temozolomide Resistance in Glioblastoma
    Zhang, Ge
    Tao, Xiang
    Ji, Baowei
    Gong, Jie
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [49] Hypoxia-Driven Gene Expression Is an Independent Prognostic Factor in Stage II and III Colon Cancer Patients
    Dekervel, Jeroen
    Hompes, Daphne
    van Malenstein, Hannah
    Popovic, Dusan
    Sagaert, Xavier
    De Moor, Bart
    Van Cutsem, Eric
    D'Hoore, Andr E.
    Verslype, Chris
    van Pelt, Jos
    CLINICAL CANCER RESEARCH, 2014, 20 (08) : 2159 - 2168
  • [50] A hypoxia-driven transcriptional program characterizes acquired resistance to immune checkpoint inhibitors in lung cancer.
    Robles-Oteiza, Camila
    Hastings, Katherine
    Kaech, Susan M.
    Politi, Katerina
    CANCER RESEARCH, 2021, 81 (13)